A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors

NCT04446260 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

396

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SHR-A1811

Sponsor

Jiangsu HengRui Medicine Co., Ltd.

Collaborators

[object Object]